The NHLBI COPD clinical research network

Pulmonary Pharmacology and Therapeutics

Volumn 17, Issue 3, 2004, Pages 111-112

  Albert, Richard K ^a  

^a DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2A RECEPTOR AGONIST; ANABOLIC AGENT; ANTIOXIDANT; ANTIVIRUS AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BLOCKING AGENT; CELL ADHESION MOLECULE; CORTICOSTEROID; ENDOTHELIN RECEPTOR ANTAGONIST; HELIOX; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LEUKOCYTE ELASTASE INHIBITOR; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; LIPOXYGENASE INHIBITOR; MACROLIDE; MATRIX METALLOPROTEINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MUCOLYTIC AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYGEN; PHOSPHODIESTERASE IV INHIBITOR; PNEUMOCOCCUS VACCINE; TACHYKININ RECEPTOR ANTAGONIST; THEOPHYLLINE; THROMBOXANE RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL RESEARCH; DISEASE EXACERBATION; INFLUENZA VACCINATION; ORGANIZATION; PRIORITY JOURNAL; SHORT SURVEY; SMOKING CESSATION;

EID: 1942422142     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pupt.2004.01.006     Document Type: Article

References (6)

1. Petty T.L. Scope of the COPD problem in North America. Early studies of prevalence and NHANES III data: basis for early identification and intervention. Chest. 117:2000;S327-S331.
2. Ward M.M., Javitz H.S., Smith W.M., Bakst A. Direct medical costs of chronic obstructive pulmonary disease in the USA. Respir Med. 94:2000;1123-1129.
3. Druss B.G., Marcus S.C., Olfson M., Pncus H.A. The most expensive medical conditions in America. Health Affairs. 21:2002;105-111.
4. Strassels S.A., Smith D.H., Sullivan S.D., Mahajan P.S. The costs of treating COPD in the United States. Chest. 119:2001;344-352.
5. Connors A.F. Jr, Dawson N.V., Thomas C., Harrell F.E. Jr, Desbiens N., Fulkerson W.J., Kussin P., Bellamy P., Goldman L., Knaus W.A. Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med. 154:1996;959-967.
6. Croxton T.L., Weinmann G.G., Senior R.M., Wise R.A., Crapo J.D., Buist A.S. Clinical research in chronic obstructive pulmonary disease. Needs and opportunities. Am J Respir Crit Care Med. 167:2003;1142-1149.